TRAW TRAWS PHARMA INC

Ownership history in MORGAN STANLEY  ·  5 quarters on record

This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in TRAWS PHARMA INC (TRAW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 719 0% 0.00% $1K $1.85
2025 Q2 REDUCED 719 -6 -0.8% 0.00% $1K $1.48
2025 Q1 REDUCED 725 -15,000 -95.4% 0.00% $2K $2.30
2024 Q4 ADDED 15,725 +14,996 +2057.1% 0.00% $140K $8.88
2024 Q3 INITIATED 729 0.00% $4K $5.88
% of Fund (quarterly)    TRAW price (monthly, adj. close)
← Back to MORGAN STANLEY Holdings